Cargando…

Beta-blocker therapy in pediatric heart failure: 50 years lost to improve pharmacotherapy of a deadly disease

Detalles Bibliográficos
Autor principal:	Buchhorn, Reiner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Invited Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457278/ https://www.ncbi.nlm.nih.gov/pubmed/34667405 http://dx.doi.org/10.4103/apc.apc_126_21

Ejemplares similares

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Lost in translation
por: Petsko, Gregory A
Publicado: (2010)

Pediatric cardiac intensive care units: The way forward
por: Varma, Amit
Publicado: (2011)

The nuts and bolts of pediatric cardiac care for the economically challenged
por: Kumar, R Krishna
Publicado: (2009)

The walking dead
por: Petsko, Gregory A
Publicado: (2011)

Pediatric cardiac care for the economically disadvantaged in India: Problems and prospects
por: Kothari, Shyam S
Publicado: (2009)

Contrast nephropathy: Risk factors and the role of beta blockers
por: Bowden, Rodney G.
Publicado: (2015)

Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword
por: Staudacher, Dawid L., et al.
Publicado: (2023)

Getting around the pandemic – lessons from the Pediatric Cardiac Society of India COVID-19 study
por: Shivaprakasha, Krishnanaik
Publicado: (2021)

Depressive disorders: Treatment failures and poor prognosis over the last 50 years
por: Blackburn, Thomas P.
Publicado: (2019)

Treating hypoplastic left heart syndrome in emerging economies: Heading the wrong way?
por: Iyer, Krishna S
Publicado: (2013)

Research in pediatric cardiac anesthesia and intensive care in low- and middle- income countries and low resource settings: Challenges and opportunities
por: Iyer, Parvathi U, et al.
Publicado: (2021)

Flogging a dead horse
por: Jobling, Mark A
Publicado: (2013)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Coronavirus is the trigger, but the immune response is deadly
por: Cron, Randy Q
Publicado: (2020)

The Fogarty International Center at 50: Accomplishments and Priorities for the Next 50 Years
por: Drain, Paul K, et al.
Publicado: (2018)

Pharmacotherapy and the Role of Pharmacists in Rehabilitation Medicine
por: Yoshimura, Yoshihiro, et al.
Publicado: (2022)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Beta-Blocker Therapy and Hemophagocytic Lymphohistiocytosis: A Case Report
por: Müller, C., et al.
Publicado: (2010)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

A lost generation? COVID-19 and adolescent mental health
por: Hafstad, Gertrud Sofie, et al.
Publicado: (2021)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

Getting to the heart of an unusual kinetochore
por: Singleton, Martin R.
Publicado: (2016)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
por: Erickson, Marc, et al.
Publicado: (2021)

Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography
por: Jones, K. A., et al.
Publicado: (2022)

Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017)

Hypertensive and cognitive function: did we come to a dead end?
por: Tadic, Marijana, et al.
Publicado: (2022)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

CARDIOPROTECTIVE MECHANISMS OF LIFESTYLE MODIFICATIONS AND PHARMACOTHERAPIES ON CARDIAC REMODELING AND DYSFUNCTION IN HYPERTENSIVE HEART DISEASE: AN OVERVIEW
por: NAGATA, KOHZO, et al.
Publicado: (2011)

Lives lost and disease burden related to antimicrobial resistance in the Americas can no longer be ignored
por: Undurraga, Eduardo A., et al.
Publicado: (2023)

Gastrointestinal Stomas and Fistulas: What is Lost and What to Do?
por: Pande, Rajesh K, et al.
Publicado: (2020)

The Importance of PTH for Heart Failure. Comment on Thiele et al. The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure. J. Clin. Med. 2022, 11, 2733
por: Grant, William B., et al.
Publicado: (2022)

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure
por: Iyngkaran, Pupalan, et al.
Publicado: (2016)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d1cncha2bkqphek58fgqkqpf86